A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results for " Octreotide "

media.product.imagealternatetextformat.details

Cyclic Methylene Octreotide Impurity

N° de SZ CAT:SZ-O034076
Número CASNA
Mol.F.C50H66N10O10S2
Peso Molecular1031.3
Status de FaturaSynthesis on demand

Nome Químico: (4S,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-10-(4-aminobutyl)-16-benzyl-19-((R)-4-benzyl-5-oxoimidazolidin-1-yl)-N-((3R)-1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

Sorrisos: O=C([C@H](NC([C@H](C(O)C)NC([C@H](CCCCN)NC([C@@H](CC1=CNC2=C1C=CC=C2)NC([C@H](CC3=CC=CC=C3)N4)=O)=O)=O)=O)CSSC[C@H](N(CN[C@@H]5CC6=CC=CC=C6)C5=O)C4=O)NC([C@H](O)C)CO

Cyclic Methylene Octreotide Impurity is chemically (4S,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-10-(4-aminobutyl)-16-benzyl-19-((R)-4-benzyl-5-oxoimidazolidin-1-yl)-N-((3R)-1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide. Cyclic Methylene Octreotide Impurity is supplied with detailed characterization data compliant with regulatory guideline. Cyclic Methylene Octreotide Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Octreotide.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.